Long-Term PPI Therapy Associated With Hip Fractures – JAMA Study
This article was originally published in The Tan Sheet
Executive Summary
Physicians should "be aware" of the potential positive association between PPI therapy and hip fractures and "should use the lowest effective dose for patients with appropriate indications," researchers conclude in a large observational study published in the Dec. 27 Journal of the American Medical Association
You may also be interested in...
Study Questions “Liberal” Proton Pump Inhibitor Use
A Canadian study supporting a link between proton pump inhibitors and osteoporosis-related fractures could lead to questions about OTC access to PPIs and shows a need to educate consumers regarding individual fracture risk, the authors say
Study Questions “Liberal” Proton Pump Inhibitor Use
A Canadian study supporting a link between proton pump inhibitors and osteoporosis-related fractures could lead to questions about OTC access to PPIs and shows a need to educate consumers regarding individual fracture risk, the authors say
Study Questions “Liberal” Proton Pump Inhibitor Use
A Canadian study supporting a link between proton pump inhibitors and osteoporosis-related fractures could lead to questions about OTC access to PPIs and shows a need to educate consumers regarding individual fracture risk, the authors say